Cite
Pietrantonio F, Morano F, Corallo S, et al. Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2019;5(9):1268-1275doi: 10.1001/jamaoncol.2019.1467.
Pietrantonio, F., Morano, F., Corallo, S., Miceli, R., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Bergamo, F., Sartore-Bianchi, A., Tampellini, M., Racca, P., Clavarezza, M., Berenato, R., Caporale, M., Antista, M., Niger, M., Smiroldo, V., Murialdo, R., Zaniboni, A., Adamo, V., Tomasello, G., Giordano, M., Petrelli, F., Longarini, R., Cinieri, S., Falcone, A., Zagonel, V., Di Bartolomeo, M., & de Braud, F. (2019). Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology, 5(9), 1268-1275. https://doi.org/10.1001/jamaoncol.2019.1467
Pietrantonio, Filippo, et al. "Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial." JAMA oncology vol. 5,9 (2019): 1268-1275. doi: https://doi.org/10.1001/jamaoncol.2019.1467
Pietrantonio F, Morano F, Corallo S, Miceli R, Lonardi S, Raimondi A, Cremolini C, Rimassa L, Bergamo F, Sartore-Bianchi A, Tampellini M, Racca P, Clavarezza M, Berenato R, Caporale M, Antista M, Niger M, Smiroldo V, Murialdo R, Zaniboni A, Adamo V, Tomasello G, Giordano M, Petrelli F, Longarini R, Cinieri S, Falcone A, Zagonel V, Di Bartolomeo M, de Braud F. Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2019 Sep 01;5(9):1268-1275. doi: 10.1001/jamaoncol.2019.1467. PMID: 31268481; PMCID: PMC6613306.
Copy
Download .nbib